showed that the two ortho-aminophenols, 3-hydroxykynurenine and 3-hydroxyanthranilic acid, induced bladder cancer under the same conditions. Higher concentrations of 3-hydroxyanthranilic acid and kynurenine have been found in the urine of patients with cancer of the bladder when compared with urine of either normal subjects or of those with cancer localized in organs other than the bladder (Boyland and WiUiams, 1955). Perhaps this indicates that a block at the level of the 3-hydroxyanthranilic oxidase (with subsequent accumulation of 3-hydroxyanthranilic acid and of 3-hydroxykynurenine) is the basis of tumours of the bladder.
We are interested in the relationship between tumours of the bladder and the metabolic by-products from tryptophan degradation and in our preceding work (Quagliariello, Auricchio, Casale and Tancredi, 1958 ; Fedele, Trancredi and Riccardi, 1959, 1961) we have discussed the possible aetiology of cancer in relation to metabohtes of tryptophan. Bonser, Clayson, Jull and Pirah (1952) have shown that some ortho-aminophenols produce cancer of the urinary bladder. Allen, Boyland, Dukes, Horning and Watson (1957) showed that the two ortho-aminophenols, 3-hydroxykynurenine and 3-hydroxyanthranilic acid, induced bladder cancer under the same conditions. Higher concentrations of 3-hydroxyanthranilic acid and kynurenine have been found in the urine of patients with cancer of the bladder when compared with urine of either normal subjects or of those with cancer localized in organs other than the bladder (Boyland and WiUiams, 1955) . Perhaps this indicates that a block at the level of the 3-hydroxyanthranilic oxidase (with subsequent accumulation of 3-hydroxyanthranilic acid and of 3-hydroxykynurenine) is the basis of tumours of the bladder. Dunning, Curtis and Mann (1956) (1) Of the three patients who never excreted 3-hydroxyanthranilic acid, biopsies showed that two did not have cancer of the bladder.
(2) All 4-i of the cases investigated were followed for 20 days. In some patients the presence of 3-hydroxyanthranilic acid in the urine was always detectable in others the excretion of this metabolite was not constant.
(3) In recent studies by others (Benassi and Perissinotto, 1959, 1960) In agreement with our earher studies (Fedele, et al., 1959 (Fedele, et al., , 1961 Quagliariello et al., 1958 ) the researches of Boyland and WiRiams (1955) , and experiments of Tompsett (1959) , the results show that 3-hydroxyanthranilic acid is usually present in the urine along with other metabohtes of the tryptophan-nicotinic acid group -kynurenine and anthranihc acid-in bladder cancer patients.
After our studies and those of others we have cited, we cannot consider research regarding the correlation between blocks in the tryptophan nicotinic acid metabohsm and cancer of the bladder as finished. However, it appears more evident that there is a relationship between metabolites of the tryptophan and cancer of the bladder.
SUMMARY
Urine from patients with bladder cancer usually contains 3-hydroxyanthranihc acid, kynurenine and anthranihc acid. The excretion of 3-hydroxyanthranilic acid is reduced by treatment with large doses of nicotinamide.
